EmerRx Biopharma, LLC

CIK 2088182 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for EmerRx Biopharma, LLC.

Recent SEC filings

FiledFormAccession number
Mar 5, 2026C-U0002088182-26-000003
Feb 19, 2026C/A0002088182-26-000002
Feb 19, 2026C/A0002088182-26-000001
Dec 31, 2025C/A0002088182-25-000005
Dec 31, 2025C/A0002088182-25-000004
Nov 19, 2025C/A0002088182-25-000003
Oct 8, 2025C/A0002088182-25-000002
Sep 25, 2025C0002088182-25-000001